PreludeDx and Learn Look Locate Team Up to Enhance Patient Education on DCIS Treatment Choices

PreludeDx Partners with Learn Look Locate for Patient Education

On July 9, 2026, Prelude Corporation, known as PreludeDx™, which specializes in precision diagnostics for early-stage breast cancer, made an important announcement about its collaboration with Learn Look Locate. This initiative aims to expand patient education surrounding treatment choices for those diagnosed with ductal carcinoma in situ (DCIS). The goal is to empower patients with essential knowledge to make informed decisions about their healthcare.

The newly created educational guide by Learn Look Locate, titled "Do I Need Radiation If I Have DCIS? A Complete, Patient-Centered Guide to Making the Right Decision for You," offers straightforward and comprehensive information regarding various aspects related to DCIS. This includes insights on the nature of the disease, the implications of a lumpectomy, the potential role of radiation therapy, understanding recurrence risks, and details regarding DCISionRT®, PreludeDx's advanced molecular test. This test is designed to provide tailored information regarding the 10-year risk of recurrence and the benefits of radiation therapy for patients diagnosed with DCIS.

Navigating a DCIS diagnosis can be exceptionally challenging, especially as patients often find themselves needing to make significant treatment choices without fully grasping what DCIS entails. The newly developed educational resource seeks to alleviate this pressure by equipping patients with relevant questions and knowledge to engage more confidently and effectively with their healthcare providers.

Dr. Barry Rosen, a breast surgeon and senior medical advisor for Learn Look Locate, elaborates on the importance of this collaboration: "It's transformative, it really is. You add an additional layer of information with DCISionRT. It's knowledge that will empower patients to make better decisions for themselves."

The president and CEO of PreludeDx, Dan Forche, emphasized the significance of patient education in critical medical decisions. "Patients diagnosed with DCIS often encounter complex choices while they are still processing their initial diagnosis. By leveraging Learn Look Locate's educational platform, we make credible, patient-friendly education more accessible. This empowers women to grasp their individual risks, the possible role of radiation therapy, and how tools like DCISionRT can inform more personalized treatment conversations with their healthcare team."

The collaborative effort is rooted in a mutual dedication to advancing access to trustworthy, patient-centered educational content on breast cancer. The newly minted guide aims to clarify key areas such as:
The unique characteristics of DCIS and its varying patient presentations.
How recurrence risks are assessed.
The significance of radiation therapy post-lumpectomy.
The ways in which DCISionRT aids in making informed treatment decisions.
* Critical questions to raise with healthcare providers when exploring treatment options.

Patients interested in this resource can find the guide available for access at Learn Look Locate. For additional insight into the DCISionRT test, detailed information is accessible at PreludeDx's official website PreludeDx.

About PreludeDx

Founded in 2009 and operating with technology licensed from the University of California, San Francisco, PreludeDx has established itself as a pioneer in the realm of personalized breast cancer diagnostics on a global scale. Committed to developing precision tools that influence treatment decisions, PreludeDx strives to enhance patient outcomes while simultaneously optimizing healthcare costs. Their approach advocates for informed decision-making, encapsulated in the slogan: "Know Your Risk™, Know Your Benefit." For further details about PreludeDx and their initiatives aimed at improving patient experiences, visit their website or follow them on social media platforms.

About Learn Look Locate

Learn Look Locate serves as a worldwide educational platform dedicated to breast cancer. It aims to guide, inform, and empower individuals as they navigate their journey from diagnosis to treatment and survivorship alongside a supportive community of patients, medical professionals, and advocacy groups. More information about their resources is available on their website.